Furthering clinicians’ understandings of how daily practice can respond to Black patients' experiences can help restore trust and mitigate racial and ethnic health inequity.
AMA J Ethics. 2021; 23(6):E480-486. doi:
10.1001/amajethics.2021.480.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021; 23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Madeleine (Maddy) Kane, Rachel Bervell, MD, MS, Angela Y. Zhang, MD, and Jennifer Tsai, MD, MEd
Algorithms use race as an epidemiological shorthand, but clinically influential historical, social, and cultural determinants of health are still sources of variability.
AMA J Ethics. 2022; 24(8):E720-728. doi:
10.1001/amajethics.2022.720.